AYALA PHARMACEUTICALS INC (AYLA) Stock Analyst Ratings
USA - NASDAQ:AYLA - US05465V1089 - Common Stock
0.5036 USD
+0.03 (+5.84%)
ChartMill assigns a Buy % Consensus number of 78% to AYLA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.24. This target is 2330.5% above the current price.
AYLA was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about AYLA.
In the last month the buy percentage rose by 28 points. So the trust of analysts is improving.
AYLA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-10-31 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2022-10-20 | Roth Capital | Downgrade | Buy -> Sell |
| 2022-09-20 | Noble Capital Markets | Downgrade | Outperform -> Market Perform |
| 2022-08-16 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-20 | Maxim Group | Initiate | Buy |
| 2021-12-20 | HC Wainwright & Co. | Initiate | Buy |
| 2021-11-30 | Jefferies | Upgrade | Hold -> Buy |
| 2021-08-17 | Oppenheimer | Maintains | Outperform |
| 2021-07-13 | Ladenburg Thalmann | Initiate | Buy |
AYALA PHARMACEUTICALS INC / AYLA FAQ
What do analysts expect the price target to be for AYALA PHARMACEUTICALS INC (AYLA)?
9 analysts have analysed AYLA and the average price target is 12.24 USD. This implies a price increase of 2330.5% is expected in the next year compared to the current price of 0.5036.
Can you provide the consensus rating for AYALA PHARMACEUTICALS INC stock?
The consensus rating for AYALA PHARMACEUTICALS INC (AYLA) is 77.7778 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for AYLA stock?
The number of analysts covering AYALA PHARMACEUTICALS INC (AYLA) is 9.